CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

181 hedge funds and large institutions have $2.54B invested in Crinetics Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 75 increasing their positions, 58 reducing their positions, and 23 closing their positions.

Holders
181
Holders Change
+10
Holders Change %
+5.85%
% of All Funds
2.65%
Holding in Top 10
9
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-30.77%
% of All Funds
0.13%
New
34
Increased
75
Reduced
58
Closed
23
Calls
$22.4M
Puts
$11.9M
Net Calls
+$10.6M
Net Calls Change
+$12.5M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$144M
2
Jennison Associates
2
Jennison Associates
New York
$90.6M
3
Morgan Stanley
3
Morgan Stanley
New York
$46.1M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$27.7M
5
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$86M

Top Sellers

1
O
1
OrbiMed
New York
$59.3M
2
FLSM
2
Frazier Life Sciences Management
California
$14.1M
3
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$0
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$122M
5
CC
5
Commodore Capital
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$190M 5,345,114 +499,397 +10%
DCM
2
Driehaus Capital Management
Illinois
$179M 5,039,957 -92,330 -2%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$144M 4,043,865 +1,903,004 +89%
State Street
4
State Street
Massachusetts
$127M 3,563,736 +711,016 +25%
Vanguard Group
5
Vanguard Group
Pennsylvania
$125M 3,502,452 +95,417 +3%
Point72 Asset Management
6
Point72 Asset Management
Connecticut
$122M 3,416,900 -808,400 -19%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$115M 3,245,105 -395,130 -11%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$107M 3,008,858 +430,659 +17%
Jennison Associates
9
Jennison Associates
New York
$90.6M 2,547,683 +1,113,992 +78%
T. Rowe Price Investment Management
10
T. Rowe Price Investment Management
Maryland
$86M 2,417,493 +776,801 +47%
PBA
11
Paradigm Biocapital Advisors
New York
$82.3M 2,312,919 +134,182 +6%
EC
12
EcoR1 Capital
California
$71.6M 2,012,517 +482,254 +32%
FLAM
13
First Light Asset Management
Minnesota
$70.7M 1,987,772 +404,443 +26%
O
14
OrbiMed
New York
$59.3M 1,667,360 -1,228,714 -42%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$48.1M 1,352,672 +82,998 +7%
Morgan Stanley
16
Morgan Stanley
New York
$46.1M 1,296,502 +785,181 +154%
PA
17
Perceptive Advisors
New York
$44.7M 1,255,512 -8,220 -0.7%
CAM
18
Cormorant Asset Management
Massachusetts
$40.9M 1,150,000 +48,096 +4%
NHAS
19
Novo Holdings A/S
Denmark
$39.1M 1,100,000 – –
EAM
20
Eventide Asset Management
Massachusetts
$37.7M 1,059,633 +40,851 +4%
SVCM
21
Saturn V Capital Management
Texas
$28M 787,132 -339,447 -30%
Lord, Abbett & Co
22
Lord, Abbett & Co
New Jersey
$27.7M 777,288 +777,288 New
IC
23
Ikarian Capital
Texas
$24.2M 680,370 -112,550 -14%
Nuveen Asset Management
24
Nuveen Asset Management
Illinois
$24.2M 679,171 +268,230 +65%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$23.5M 659,921 -84,895 -11%
1
2 3 4 5